Skip to main content
Peptide compounds discussed on this site are for educational and research purposes. Always consult a qualified specialist before use.
Reference Sermorelin 5mg FOR RESEARCH
Approved Evidence Stage
Longevity Primary Domain
Subcutaneous injection Routes Studied
200+ PubMed Citations
Longevity Peptide
Approved Therapeutic

Sermorelin

Synthetic peptide studied in clinical and preclinical models for natural gh pattern restoration and body composition improvement

Last updated: March 1, 2026

Compound Data Sheet
Peer-reviewed References
Evidence Graded
Independent Editorial
Compound
Sermorelin
Class
Longevity peptide
Summary
Synthetic peptide studied in clinical and preclinical models for natural gh pattern restoration, body composition improvement, sleep quality enhancement.
Mechanism
Downstream IGF-1 & Tissue Effects
Research Status
Approved
Routes Studied
Subcutaneous injection
Evidence Level
Clinically validated · Approved therapeutic
[ QUICK.ANSWERS ]

What Should You Know About Sermorelin?

What is Sermorelin?
Sermorelin is a synthetic peptide studied in clinical and preclinical models for natural gh pattern restoration and body composition improvement.
Is Sermorelin clinically proven?
Sermorelin is an approved therapeutic with established clinical evidence.
What has Sermorelin been studied for?
Sermorelin has been studied in clinical and preclinical settings of natural gh pattern restoration, body composition improvement, sleep quality enhancement and has received regulatory approval in at least one jurisdiction.
Is Sermorelin approved?
Sermorelin is an approved therapeutic in at least one jurisdiction. Regulatory status varies by country. Consult a local specialist for guidance.
[ COMPOUND.PROFILE ]

What Is Sermorelin?

Sermorelin is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH), consisting of the first 29 amino acids of the naturally occurring 44-amino-acid GHRH molecule. These 29 amino acids represent the biologically active fragment responsible for stimulating growth hormone (GH) secretion from the anterior pituitary gland. First developed in the 1980s, sermorelin was FDA-approved in 1997 under the brand name Geref for the diagnosis and treatment of growth hormone deficiency...

[ EVIDENCE.SUMMARY ]

Evidence Summary

Clinically validated · Approved therapeutic

Sermorelin is an approved therapeutic with established clinical evidence and regulatory approval in at least one jurisdiction.

Evidence Breakdown

Domain Evidence Level
Natural GH Pattern Restoration Limited
Body Composition Improvement Limited
Sleep Quality Enhancement Limited
Anti-Aging & Recovery Support Limited
Human clinical evidence Established
Safety data Established
Deep Research Score 2.5 / 5 See full review

Editorial Position

Sermorelin is an approved therapeutic with established clinical evidence. As with any pharmaceutical compound, individual suitability should be discussed with a specialist.

Regulatory Status Snapshot

  • Approved as a therapeutic drug in at least one jurisdiction
  • Safety and efficacy established through regulatory review processes

Need help interpreting this evidence for your situation?

Talk to a Specialist
[ STUDIED.FOR ]

What Has Sermorelin Been Studied For?

Research areas where Sermorelin has been investigated in published studies

  • Natural GH Pattern Restoration Sermorelin has been studied in clinical and preclinical studies of natural gh pattern restoration.
  • Body Composition Improvement Sermorelin has been studied in clinical and preclinical studies of body composition improvement.
  • Sleep Quality Enhancement Sermorelin has been studied in clinical and preclinical studies of sleep quality enhancement.
  • Anti-Aging & Recovery Support Sermorelin has been studied in clinical and preclinical studies of anti-aging & recovery support.
[ MECHANISM ]

How Does Sermorelin Work?

These mechanisms have been established through clinical and preclinical research.

  1. 01 GHRH Receptor Binding
  2. 02 Intracellular signaling
  3. 03 Pulsatile GH Release
  4. 04 Feedback Loop Preservation
NEXT STEP

Not sure if Sermorelin is right for you?

A specialist can review the evidence, evaluate your medical context, and help you make an informed decision about Sermorelin.

Speak with a Specialist
[ COMMUNITY.FEEDBACK ]

Community Reports (Anecdotal)

Experiences shared here are self-reported and do not represent clinical evidence.

Rate Sermorelin

Your privacy is protected. Share anonymously if you prefer.
Your Rating
[ ADMINISTRATION ]

How Is Sermorelin Administered?

Sermorelin is available via Subcutaneous injection. Appropriate use and protocol should be determined by a qualified specialist.

[ REFERENCE.DATA ]

What Are the Specifications of Sermorelin?

Format Lyophilized Powder
Amount 5mg per vial
Purity >99%
Purity Method HPLC (High-Performance Liquid Chromatography)
Sequence Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2
Molecular Weight 3357.93 g/mol
Storage Store lyophilized powder at -20°C. Reconstituted solution at 2-8°C. Protect from light.
Appearance White to off-white lyophilized powder
[ EXPLORE ]

What Conditions Has Sermorelin Been Linked To?

Have Questions About Sermorelin?

A specialist will typically order baseline IGF-1 levels, fasting glucose, HbA1c, complete thyroid panel (TSH, Free T3, Free T4), and comprehensive metabolic panel. Follow-up blood work at 4-8 week intervals monitors response and ensures metabolic markers remain healthy.

Published studies on Sermorelin can be found on PubMed and other peer-reviewed databases. Our references section below lists key citations.

Sermorelin is available as a research compound in Thailand. Consult a qualified specialist to discuss whether it is appropriate for your needs.

[ PUBLISHED.RESEARCH ]

What Does the Published Research Say?

  1. Growth hormone-releasing hormone: clinical studies and therapeutic aspects

    Corpas E, Harman SM, Blackman MR. Journal of Clinical Endocrinology & Metabolism, 77(1) (1993).

  2. Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial

    Nass R, Pezzoli SS, Oliveri MC, Patrie JT, Harrell FE Jr, Clasey JL, Heymsfield SB, Bach MA, Vance ML, Thorner MO. Journal of Clinical Endocrinology & Metabolism, 93(9) (2008).

  3. Sermorelin: a better approach to management of adult-onset growth hormone insufficiency?

    Walker RF. Clinical Interventions in Aging, 1(4) (2006).

Ready to discuss Sermorelin with a specialist?

Get evidence-based guidance tailored to your health goals and medical context.

Book a Consultation Free initial consultation. No obligation.
EDITORIAL REVIEW

Reviewed by the Peptide Science Thailand Editorial Team.

Last reviewed: March 1, 2026

Share Your Experience

Not Medical Advice

The information provided on this website, including compound profiles, mechanism of action explanations, research summaries, dosage information, and educational content, is for informational and educational purposes only. This information does not constitute medical advice, diagnosis, or treatment recommendations. No content on this website should be interpreted as a substitute for professional medical advice, diagnosis, or treatment.

Medical Supervision Essential

All peptide compounds discussed on this website should only be used under the supervision of a qualified specialist. A healthcare provider should evaluate individual health status, medical history, current medications, and specific health objectives before any peptide use. Self-administration of research peptides without medical supervision is strongly discouraged and may pose significant health risks.

Individual Variation

Individual responses to peptide compounds vary significantly based on genetics, age, body composition, existing health conditions, concurrent medications, and other biological factors. Dosage information provided on this website represents general research ranges and should not be used for self-dosing. A qualified specialist should determine the appropriate compound, dosage, administration route, cycle duration, and monitoring protocol based on individual health assessment.

Liability Limitation

Peptide Science Thailand assumes no liability for the misuse of information provided on this website. The content is provided for educational purposes only. Users are responsible for ensuring they work with qualified healthcare providers before using any peptide compounds discussed herein. Peptide Science Thailand is not responsible for adverse effects resulting from use without proper medical oversight.

Regulatory Status

Many peptides discussed here have not been evaluated or approved by the FDA for therapeutic use unless specifically noted (e.g., Tesamorelin, PT-141). The regulatory status of peptide compounds varies by jurisdiction. Some compounds discussed on this website are approved medications in other countries (e.g., Semax and Selank in Russia). This content is for informational and educational purposes only. Users are responsible for understanding and complying with all applicable laws and regulations in their jurisdiction.